Transformation of Parkinson’s care through Self-Management, Remote monitoring and Timely review (SMaRT-PD): Care Pathway Mapping with Clinical Experts
Objective: To elicit healthcare professionals’ perspectives on the introduction of a clinical decision support system (CDSS) to facilitate Parkinson’s disease care provision: impact on current…Utility of Digital Olfactory Assessment (Sensify) in Parkinson’s Disease: Preliminary Findings from the IPDGC Africa in Egypt
Objective: Validate a digital olfactory assessment for Parkinson’s disease (PD) in Egyptian participants by comparing olfactory performance in PD patients, healthy controls, and those with…Artificial Intelligence for Understanding Parkinson Disease State and Patient Stratification Using CSF Proteomics
Objective: The objective of this research is to employ an Artificial Intelligence (AI) approaches to identify patient status and disease states in neurodegenerative diseases (NDDs),…Diagnostic Work Up when Suspecting Early Onset Parkinson Disease (EOPD) Recommendations from the MDS EOPD Study Group
Objective: Objective: To establish recommendations regarding which investigations are needed for the diagnosis of Early onset Parkinson’s disease (EOPD) Background: Background: EOPD has been defined…Parkinson’s Disease Dogs to assist Gait Impairment: A Pilot study of Patient Experience and Outcomes
Objective: This pilot study was designed to evaluate Parkinson's disease assistance dogs as a novel non-pharmacological therapy for gait impairment in Parkinson's disease Background: Gait…An Exercise Prescription to Slow the Progression of Parkinson’s Disease
Objective: To evaluate the efficacy of a 12-month, home-based, high-intensity aerobic exercise intervention in slowing the progression of Parkinson’s disease (PD) using rate-focused cycling. Background:…Opicapone in Parkinson’s Patients with Probable REM Sleep Behavior Disorder: Insights from the OASIS Trial
Objective: To evaluate opicapone’s effect on sleep disturbances, motor and non-motor symptoms and quality of life in Parkinson's disease (PD) patients with and without probable…Effect of Exenatide on disease progression in early Parkinson’s disease–a randomized, placebo controlled, single-center trial in Sweden
Objective: To identify biological mechanisms that mediate Exenatide's effect in the brain of patients with early Parkinson’s disease(PD). Background: Tracking PD progression remains a major challenge due to…Identifying subjects at high risk for prodromal Parkinson’s Disease using dopamine transporter imaging deficit in a step-wise recruitment strategy: Data of Healthy Brain Ageing (HeBA)
Objective: To optimize screening for subjects with dopamine transporter (DaT) imaging deficit being at high risk for prodromal Parkinson's disease (PD). Background: Efficient screening methods…Efficacy and Safety of Different Apomorphine Formulations for OFF Episodes in Parkinson’s Disease: A Systematic Review and Meta-Analysis
Objective: To assess the efficacy and safety of different apomorphine formulations for managing OFF episodes in Parkinson’s disease (PD) through a systematic review and meta-analysis.…
- « Previous Page
- 1
- …
- 88
- 89
- 90
- 91
- 92
- …
- 436
- Next Page »